Epigenetic Dysregulation and Ageing (the mechanisms behind epigenetic clocks)

What Changes with Age

Ageing is associated with broad changes in DNA methylation, chromatin organization, and transcriptional control. These changes are not random in a uniform sense: some regions lose methylation with age, others gain it, and the affected sites are enriched in functionally important genomic contexts. The hallmarks framework treats these shifts as part of the wider category of epigenetic alterations, while genome-scale studies show that age-related methylation change can be detected across multiple tissues. [1] [2] [3]

Why Epigenetic Clocks Work at All

Epigenetic clocks work because a subset of CpG sites changes with age in reproducible ways. Early blood and pan-tissue clocks showed that these methylation patterns can estimate chronological age with high accuracy across many samples, even though the specific CpGs used by different clocks overlap only partially. This suggests that clocks are reading a broader ageing-related structure in the methylome, not a single universal “age gene.” [4] [5] [3]

Developmental Programs and Chromatin State

One of the most consistent findings is that age-related methylation gain often occurs at Polycomb- and bivalent-chromatin-associated developmental genes. That pattern was visible in early human studies and remains prominent in more recent cross-species work, where age-sensitive CpGs are strongly enriched at PRC2-binding sites and genes involved in development. For that reason, many researchers interpret epigenetic clocks as capturing an interaction between developmental gene regulation and later-life maintenance, rather than simple accumulated noise alone. [2] [6] [7] [3]

Replication, Tissue Turnover, and Cell Composition

Clock signals also appear to reflect cell replication history and tissue context. Horvath's original pan-tissue clock correlated with cell passage number, and separate methylation models such as epiTOC were explicitly constructed to approximate mitotic history from CpGs at Polycomb target genes. At the same time, blood-based age estimates are influenced by age-related shifts in immune-cell composition, which means part of a clock signal can come from changes in which cells are present, not only changes within each cell. [5] [8] [9]

What Reprogramming Suggests About Mechanism

Reprogramming studies provide an important clue because epigenetic age can fall sharply as cells move toward a pluripotent state. In the original pan-tissue clock, embryonic and induced pluripotent stem cells had very low methylation age, and later work showed that partial reprogramming can reduce epigenetic age before full loss of somatic identity. This supports the view that clock signals depend on plastic regulatory states, not on an irreversible one-way damage marker, although it does not prove that resetting a clock fully resets organismal ageing. [5] [10]

What the Clocks Probably Measure

The safest interpretation is that epigenetic clocks measure a composite of processes: developmental gene regulation, epigenetic maintenance fidelity, replication-associated change, and in some tissues shifts in cell composition. Different clocks weight these components differently depending on their training targets and tissues. That is why clocks can be informative biomarkers of ageing while still leaving the deeper causal question unresolved. [3] [7] [8] [9]

Related Reading

• Epigenetic Clocks
• Hallmarks of Ageing
• Cellular Reprogramming and Age Reversal
• Why Ageing Is Not a Single Process

Summary

Epigenetic dysregulation in ageing is best understood as a patterned shift in gene-regulatory state, not just random methylation drift. Epigenetic clocks are useful because they capture stable signatures of that shift, but the evidence suggests they are reading several overlapping mechanisms rather than one isolated biological clockwork. [1] [3] [7]

References

1. Lopez-Otin, C. et al. "Hallmarks of aging: An expanding universe." Cell (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10809922/
2. Rakyan, V. K. et al. "Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains." Genome Research (2010). https://pmc.ncbi.nlm.nih.gov/articles/PMC2847746/
3. Horvath, S., & Raj, K. "DNA methylation-based biomarkers and the epigenetic clock theory of ageing." Nature Reviews Genetics (2018). https://www.nature.com/articles/s41576-018-0004-3
4. Hannum, G. et al. "Genome-wide methylation profiles reveal quantitative views of human aging rates." Genome Research (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC3780611/
5. Horvath, S. "DNA methylation age of human tissues and cell types." Genome Biology (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC4015143/
6. Teschendorff, A. E. et al. "Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer." Genome Research (2010). https://pmc.ncbi.nlm.nih.gov/articles/PMC2847747/
7. Lu, A. T. et al. "Universal DNA methylation age across mammalian tissues." Nature Aging (2023). https://www.nature.com/articles/s43587-023-00462-6
8. Yang, Z. et al. "Correlation of an epigenetic mitotic clock with cancer risk." Genome Biology (2016). https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1064-3
9. Reynolds, L. M. et al. "Deciphering the role of immune cell composition in epigenetic age acceleration: Insights from cell-type deconvolution applied to human blood epigenetic clocks." Aging Cell (2024). https://pubmed.ncbi.nlm.nih.gov/38146185/
10. Olova, N. et al. "Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity." Aging Cell (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6351826/